Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters

Brain Research

Volumn 756, Issue 1-2, 1997, Pages 153-159

  Attali, Gitit ^a   Weizman, Abraham ^a   Gil Ad, Irit ^a   Rehavi, Moshe ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Methyltestosterone; 3H BTCP; 3H Imipramine; Dopamine transporter; Estradiol; Gonadectomy; Progesterone; Serotonin transporter

Indexed keywords

1 [1 (2 BENZO[B]THIENYL)CYCLOHEXYL]PIPERIDINE; CARRIER PROTEIN; DOPAMINE TRANSPORTER; ESTRADIOL; IMIPRAMINE; METHYLTESTOSTERONE; PROGESTERONE; SEROTONIN; SEROTONIN TRANSPORTER; SEX HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASTRATION; CONTROLLED STUDY; DOPAMINE UPTAKE; FEMALE; HORMONAL REGULATION; MALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE;

ANIMALS; BRAIN; CARRIER PROTEINS; DOPAMINE AGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ESTRADIOL; FEMALE; IMIPRAMINE; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; OVARIECTOMY; PHENCYCLIDINE; PROGESTERONE; RATS; RATS, INBRED STRAINS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 0030951961     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00136-4     Document Type: Article

References (55)

1. Abraham, G.E., O'Dell, W.D., Swerdloff, R.S. and Hopper, K., Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone and estradiol-17β during the menstrual cycle, J. Clin. Endocrinol. Metab., 34 (1972) 316-321.
2. 3H]GBR 12935 in Alzheimer's disease. Eur. Neurol., 30 (1990) 181-185.
3. 3H]GBR 12935 binding in vivo in mouse brain: labelling of a piperazine acceptor site, Eur. J. Neurochem., 166 (1987) 493-504.
4. Becker, J.B., Estrogen rapidly potentiates amphetamine-induced striatal dopamine release and rotational behavior during microdialysis, Neurosci. Lett., 118 (1990) 169-171.
5. Bedard, P.J., Langelier, P., Dankova, J., Villeneuve, A., Di Paolo, T., Barden, N., Labrie, F., Boissier, J.R. and Euvrard, C., Estrogens, progesterone and the extrapyramidal system, Adv. Neurol., 24 (1979) 411-422.
6. Bernardi, M., Sandrini, M., Vergoni, A.V., Marrama, D., Tagliavini, S. and Betolini, A., Influence of gonadotropin-releasing hormone on castration-induced 'depression' in mice: a behavioral and binding study, Eur. J. Pharmacol., 187, (1990) 501-506.
7. Biegon, A., Bercovitz, H. and Samuel, D., Serotonin receptor concentration during the estrous cycle of the rat, Brain Res., 187 (1980) 221-225.
8. Briely, M.S., Langer, S.Z., Raisman, R., Sechter, D. and Zarifian, E., Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients, Science, 209 (1980) 303-305.
9. Chang, S.S. and Renshaw, D.C., Psychosis and pregnancy, Compr. Ther., 12 (1986) 36-41.
10. Cicin-Sain, L., Jernej, B. and Magnus, V., Platelet serotonin levels and gonadal hormones in rats, Life Sci., 45 (1989) 1885-1892.
11. 3H]GBR 12935 binding to the dopamine uptake site in post mortem brain tissue in schizophrenia, J. Neural Transm., 77 (1989) 227-285.
12. Di Paolo, T., Levesque, D. and Diagle, M., A physiological dose of progesterone affects rat striatum biogenic amine metabolism, Eur. J. Pharmacol., 125 (1986) 11-16.
13. Di Paolo, T., Modulation of brain dopamine transmission by sex steroids, Rev. Demosci., 5 (1994) 27-42.
14. Flor-Henry, P., Schizophrenia: sex differences, Can. J. Psychiatry, 30 (1985) 319-322.
15. Glazer, W.M., Naftolin, F., Morgenstern, H., Barnea, E.R., MacLusky, N.J. and Brenner, L.M., Estrogen replacement and tardive dyskinesia, Psychoneuroendocrinology, 10 (1985) 345-350.
16. 3H]GBR 12935 labels mainly the piperazine acceptor site in the rat prefontal cortex, Brain Res., 674 (1995) 205-210.
17. Greengrass, P.M. and Tonge, S.R., Some effects of the acute and chronic administration of sex hormones on brain monoamine concentrations, Br. J. Pharmacol., 47 (1973) 660-661.
18. Haberland, N. and Hetey, L., Alterations of the synaptosomal catecholamine uptake in postmortem brain regions in schizophrenia, J. Neural Transm., 68 (1987) 303-313.
19. Hafner, H., Behrens, S., DeVry, J. and Gattaz, W.F., Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission, Eur. Arch. Psychiatry Clin. Neurosci., 241 (1991) 65-68.
20. 3H]GBR-12935 binding sites in human striatal membranes: binding characteristics and changes in parkinsonians and schizophrenics, Jpn. J. Pharmacol., 47 (1988) 237-243.
21. Hruska, R.E. and Silbergeld, E.K., Increased dopamine receptor sensitivity after estrogen treatment using the rat rotation model, Science, 208 (1980) 1466-1468.
22. Iversen, L.L., Uptake processes for biogenic amines. In L.L. Iversen, S.D. Iversen and S.H. Snyder (Eds.), Handbook of Psychopharmacology, Vol. 3, Plenum Press, New York, 1975, pp. 381-442.
23. Jeste, D.V., Lohr, J.B., Clarck, K. and Wyatt, R.J., Pharmacological treatment of tardive dyskinesia in the 1980s, J. Clin. Psychopharmacol., 8 (Suppl.) (1988) 38S-48S.
24. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193 (1951) 265-270.
25. 3H]GBR-12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsey. Eur. J. Pharmacol., 156 (1988) 331-340.
26. Marneros, A., Frequency of occurrence of Schneider's first rank symptoms in schizophrenia, Eur. Arch. Psychiatry Neurol. Sci., 234 (1984) 78-82.
27. McEwen, B.S. and Parsons, B.S., Gonadal steroid action on the brain: neurochemistry and neuropharmacology, Annu. Rev. Pharmacol. Toxicol., 22 (1982) 555-598.
28. Morissette, M. and Di Paolo, T., Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites, J. Neurochem., 60 (1993) 1876-1883.
29. Morissette, M. and Di Paolo, T., Sex and estrous cycle variations of rat striatal dopamine uptake sites, Neuroendocrinology, 58 (1993) 16-22.
30. 3H]GBR-12395 binding proteins, Arch. Biochem. Biophys., 276 (1990) 424-432.
31. Paul, S.M., Rehavi, M., Skolnick, P., Ballenger, J.C. and Goodwin, F.K., Depressed patients have decreased binding of tritiated imipramine to platelet serotonin 'transporter', Arch. Gen. Psychiatry, 38 (1981) 1315-1317.
32. Paul, S.M., Rehavi, M., Skolnick, P. and Goodwin, F.K., High affinity binding of antidepressants to biogenic amine transport sites in human brain and platelet: studies in depression. In R.M. Post and J.C. Ballenger (Eds.), Neurobiology of Mood Disorders, Williams and Wilkins, Baltimore, MD, 1984, pp. 846-853.
33. Pearce, B.K., Seeman, P., Jellinger, K. and Tourtellote, W.W., Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia, Eur. Neurol., 30 (Suppl. 1) (1990) 9-14.
34. 3H]imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors, Psychopharmacology, 89 (1986) 456-461.
35. Raisman, R., Briley, M. and Langer, S.Z., Specific tricyclic antidepressants binding sites in rat brain, Nature, 281 (1979) 148-150.
36. 3H]imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers, Psychopharmacology, 75 (1981) 368-371.
37. Rapkin, A.J., The role of serotonin in premenstrual syndrome, Clin. Obstet. Gynecol., 35 (1992) 629-636.
38. 3H]imipramine binding in male rat frontal cortex, Eur. J. Pharmacol., 107 (1985) 395-396.
39. Rector, N.A. and Seeman, M.V., Auditory hallucinations in women and men, Schizophr. Res., 1 (1992) 233-236.
40. Rehavi, M., Sepcuti, H. and Weizman, A., Upregulation of imipramine binding and serotonin uptake by estradiol in female rat brain, Brain Res., 410 (1987) 135-139.
41. 3H]Imipramine binding in discrete brain areas is affected by castration in male rats, Brain Res., 496 (1989) 29-34.
42. Seeman, M.V. and Lang, M., The role of estrogens in schizophrenia gender differences, Schizophr. Bull., 16 (1990) 185-194.
43. Seeman, P. and Niznik, H.B., Dopamine receptors and transporters in Parkinson disease and schizophrenia. FASEB J., 4 (1990) 2737-2744.
44. Singer, H.S., Hahn, B.A. and Moran, T.H., Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome, Ann. Neurol., 30 (1991) 558-562.
45. Stanley, M., Virgilio, J. and Gershon, S., Tritiated imipramine binding sites are decreased in the frontal cortex of suicides, Science, 216 (1982) 137-139.
46. 3H]imipramine binding to different regions of rat brain, Eur. J. Pharmacol., 119 (1985) 225-257.
47. Tuomisto, J. and Tukiainen, E., Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients, Nature, 262 (1976) 596-598.
48. Van Hartesveldt, C. and Joyce, J.N., Effects of estrogen on the basal ganglia. Neurosci. Biobehav. Rev., 10 (1986) 1-14.
49. 3H]BTCP: a new phencyclidine analog selective for the dopamine uptake complex, Eur. J. Pharmacol., 148 (1988) 427-436.
50. Villeneuve, A., Langelier, P. and Bedard, P., Estrogens dopamine and dyskinesia, Can. Psychiatr. Assoc. J., 23 (1978) 68-70.
51. Weizman, A., Carmi, M., Hermesh, H., Shahar, A., Apter, A., Tyano, S. and Rehavi, M., High affinity imipramine binding and serotonin uptake in platelets of adolescents and adult obsessive compulsive patients, Am. J. Psychiatry, 143 (1986) 335-339.
52. Weizman, A., Carmi, M., Tyano, S., Apter, A. and Rehavi, M., High affinity imipramine binding and serotonin uptake in platelets of adolescent females suffering from anorexia nervosa, Life Sci., 38 (1986) 1235-1242.
53. 3H]imipramine binding sites, Psychiatry Res., 23 (1988) 23-29.
54. Yassa, R. and Jeste, D.V., Gender differences in tardive dyskinesia: a critical review of the literature, Schizophr. Bull., 18 (1992) 701-715.
55. Zelnik, N., Angel, I., Paul, S.M. and Kleinman, J.E., Decreased density of human striatal dopamine uptake sites with age, Eur. J. Pharmacol., 126 (1986) 175-176.